Your browser doesn't support javascript.
loading
Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial.
Cross, Gail B; Sari, Intan P; Kityo, Cissy; Lu, Qingshu; Pokharkar, Yogesh; Moorakonda, Rajesh B; Thi, Han-Nguyen; Do, Quyet; Dalay, Victoria B; Gutierrez, Emmanuel; Balanag, Vincent M; Castillo, Randy J; Mugerwa, Henry; Fanusi, Felic; Kwan, Philip; Chew, Ka Lip; Paton, Nicholas I.
Afiliación
  • Cross GB; Infectious Disease Translational Research Programme, National University of Singapore, Singapore; Department of Medicine, National University Health Systems, Singapore. Electronic address: gail.cross@burnet.edu.au.
  • Sari IP; Department of Medicine, National University Health Systems, Singapore.
  • Kityo C; Joint Clinical Research Centre, Kampala, Uganda.
  • Lu Q; Singapore Clinical Research Institute, Singapore.
  • Pokharkar Y; Singapore Clinical Research Institute, Singapore.
  • Moorakonda RB; Singapore Clinical Research Institute, Singapore.
  • Thi HN; Respiratory Center, Viet Nam Military Medical University, Hanoi, Viet Nam.
  • Do Q; Respiratory Center, Viet Nam Military Medical University, Hanoi, Viet Nam.
  • Dalay VB; De La Salle Medical and Health Sciences Institute, Manila, Philippines.
  • Gutierrez E; De La Salle Medical and Health Sciences Institute, Manila, Philippines.
  • Balanag VM; Lung Center of the Philippines, Quezon City, Philippines.
  • Castillo RJ; Lung Center of the Philippines, Quezon City, Philippines.
  • Mugerwa H; Joint Clinical Research Centre, Kampala, Uganda.
  • Fanusi F; Infectious Disease Translational Research Programme, National University of Singapore, Singapore.
  • Kwan P; Infectious Disease Translational Research Programme, National University of Singapore, Singapore.
  • Chew KL; Department of Microbiology, National University Health Systems, Singapore.
  • Paton NI; Infectious Disease Translational Research Programme, National University of Singapore, Singapore; Department of Medicine, National University Health Systems, Singapore; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
Lancet Infect Dis ; 23(7): 847-855, 2023 Jul.
Article en En | MEDLINE | ID: mdl-36966799
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis / Tuberculosis Pulmonar Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis / Tuberculosis Pulmonar Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article